Immudyne Inc (IMMD) 0.2500 $IMMD ImmuDyne Signs

New Post Public Reply Private Reply Replies (0) Message Board

Sep 26, 2016 at 9:06 AM

Immudyne Inc (IMMD) 0.2500 $IMMD

ImmuDyne Signs Exclusive License Agreement for Proprietary Dermatologist Backed Hair Loss Product
GlobeNewswire - Fri Sep 09, 7:00AM CDT
ImmuDyne (OTCQB:IMMD), a leader in the development and marketing of OTC health and wellness products addressing large unmet needs, today announced the signing of a definitive agreement with Pilaris Laboratories, LLC ("Pilaris"

, for a sole and exclusive worldwide license to commercialize the patented PilarisMax line of hair loss products.

lmmuDyne Announces Q2 2016 Net Sales Up 343%, Adjusted Non-GAAP Net Income
GlobeNewswire - Mon Aug 15, 7:30AM CDT
lmmuDyne (OTCQB:IMMD) announced today its financial results for the quarter ended June 30, 2016 and provided an update on its interim results for the first six weeks of Q3 2016.

ImmuDyne Appoints Two Industry Leaders to Newly-Formed Business Development Advisory Board
GlobeNewswire - Wed Jun 01, 10:41AM CDT
ImmuDyne (OTCQB:IMMD) announced today the appointment of Messrs. Adam Lefton and Michael Levin to a newly-formed advisory board formed to explore further commercialization opportunities for the Company's proprietary oral beta-glucan products.
NHC.TO: 4.50 (-0.05), HLTH: 3.41 (-0.09)

ImmuDyne Engages One Equity Research to Reach New Investors With Company's Value Proposition
GlobeNewswire - Thu Dec 10, 7:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) today announced that it has engaged One Equity Research LLC ("One Equity"

to provide advisory services and research covering milestone or inflection points in the Company's development.

ImmuDyne and Innate Scientific Announce Collaboration and Licensing Agreement to Launch National Skin Care Line Based on ImmuDyne's Yeast Beta Glucan Technology Portfolio
GlobeNewswire - Tue Oct 13, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD), a health, wellness and skincare company commercializing a portfolio of proprietary topical and orally delivered products that rely on ImmuDyne's patented and pure Yeast Beta Glucan ingredients, has entered into a semi-exclusive marketing agreement with Innate Scientific, LLC to launch a complete skin care regime that will be based primarily on strategic ingredients provided by ImmuDyne. Innate Scientific's leadership team has deep experience in the direct marketing space and an impressive track record creating national brands expeditiously and profitably. Importantly, Innate Skincare's founders have agreed to provide up to $2,000,000 in non-dilutive capital to finance direct marketing initiatives.

ImmuDyne Sales Continue to Improve, Sees Earnings Ahead
GlobeNewswire - Thu Oct 01, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) ImmuDyne today announced nine month revenues grew to $844,268 in 2015 from $554,509 in 2014. Revenues for the 3 quarter rose 40%, year over year, to approximately $279,000. As previously reported, ImmuDyne is capitalizing on its strong Intellectual Property and is pursuing additional sales and marketing opportunities, while continuing strong expense controls.

Sven Rohmann M.D., PhD, M.B.A. Joins the Board of Directors at Immudyne, as the Company Prepares to Announce a Lead Application for Its Proprietary Oral and Topical Delivery Technology
GlobeNewswire - Wed Sep 16, 8:34AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) - announced today that Sven Rohmann M.D., PhD, M.B.A. has joined its Board of Directors.
MRK: 62.96 (-0.06)

ImmuDyne Progress Report
GlobeNewswire - Thu Apr 02, 10:59AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announces 1 quarter revenues rose more than 50%, year over year, to approximately $288,000. Additionally, as reported in its recent 10K, ImmuDyne is hiring additional sales and marketing executives, each with performance based contracts, allowing ImmuDyne to continue to manage strong expense controls.
MRK: 62.96 (-0.06)

IPA Endorses ImmuDyne Line of Immune Support Supplements
GlobeNewswire - Thu Mar 26, 11:48AM CDT
Today, ImmuDyne (immd) announced that the Independent Pharmacy Alliance will endorse ImmuDyne's full line of Immune Support Products. IPA President John Giampolo stated, "I have been using INR Wellness for more than 10 years and my enhanced immune system has protected me beyond all my expectations. You may recall that about 10 years ago, IPA launched a complex vitamin program to complement your patients' particular disease states. During the educational process to over 600 IPA members provided by many PhD nutritional experts, I discovered ImmuDyne and how its preventative impact affected me. I can highly recommend this product for all members, their families and their patients. Because of my experience, IPA has contracted with ImmuDyne at very special and affordable pricing. Your patients will surely appreciate your care when their resistance to seasonal illness improves."

ImmuDyne Hires Todd Goldman as Senior Vice President of Marketing and Sales
GlobeNewswire - Tue Feb 10, 8:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today the hiring of Todd Goldman as Senior Vice President of Marketing and Sales.

ImmuDyne Teams Again With HellaWella
GlobeNewswire - Thu Feb 05, 10:01AM CST
ImmuDyne, Inc. (OTCQB:IMMD) and media partner HellaWella announced today the second published content ("An aging immune system puts you at higher risk for viral illnesses and cancer. Here's how to fight back" by Dr. Stephen Petteruti), which can be accessed here:

ImmuDyne Teams With HellaWella
GlobeNewswire - Mon Jan 26, 10:12AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today that It has chosen HellaWella as a media partner. The first published content can be accessed here:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...